vs

Side-by-side financial comparison of Hanover Bancorp, Inc. (HNVR) and IRIDEX CORP (IRIX). Click either name above to swap in a different company.

Hanover Bancorp, Inc. is the larger business by last-quarter revenue ($18.6M vs $14.7M, roughly 1.3× IRIDEX CORP). On growth, Hanover Bancorp, Inc. posted the faster year-over-year revenue change (3.3% vs -69.7%). Over the past eight quarters, IRIDEX CORP's revenue compounded faster (11.9% CAGR vs 6.1%).

Hanover Bancorp, Inc. is a U.S. regional bank holding company based in Maryland. It offers retail and commercial banking services including deposits, business loans, mortgages, personal lending and wealth management, serving consumers, SMEs and local groups across Maryland and adjacent mid-Atlantic markets.

IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.

HNVR vs IRIX — Head-to-Head

Bigger by revenue
HNVR
HNVR
1.3× larger
HNVR
$18.6M
$14.7M
IRIX
Growing faster (revenue YoY)
HNVR
HNVR
+73.1% gap
HNVR
3.3%
-69.7%
IRIX
Faster 2-yr revenue CAGR
IRIX
IRIX
Annualised
IRIX
11.9%
6.1%
HNVR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HNVR
HNVR
IRIX
IRIX
Revenue
$18.6M
$14.7M
Net Profit
$33.0K
Gross Margin
37.2%
Operating Margin
0.7%
Net Margin
0.2%
Revenue YoY
3.3%
-69.7%
Net Profit YoY
-99.2%
EPS (diluted)
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HNVR
HNVR
IRIX
IRIX
Q4 25
$18.6M
$14.7M
Q3 25
$18.0M
$12.5M
Q2 25
$18.4M
$13.6M
Q1 25
$18.4M
$11.9M
Q4 24
$18.0M
$12.7M
Q3 24
$17.1M
$11.6M
Q2 24
$16.9M
$12.6M
Q1 24
$16.5M
$11.8M
Net Profit
HNVR
HNVR
IRIX
IRIX
Q4 25
$33.0K
Q3 25
$3.5M
$-1.6M
Q2 25
$2.4M
$-994.0K
Q1 25
$1.5M
$-1.7M
Q4 24
$3.9M
$-834.0K
Q3 24
$3.5M
$-1.9M
Q2 24
$844.0K
$-2.7M
Q1 24
$4.1M
$-3.5M
Gross Margin
HNVR
HNVR
IRIX
IRIX
Q4 25
37.2%
Q3 25
32.1%
Q2 25
34.5%
Q1 25
42.5%
Q4 24
44.0%
Q3 24
37.3%
Q2 24
40.7%
Q1 24
37.9%
Operating Margin
HNVR
HNVR
IRIX
IRIX
Q4 25
0.7%
Q3 25
25.9%
-11.3%
Q2 25
18.4%
-6.9%
Q1 25
9.6%
-1.7%
Q4 24
28.9%
-3.9%
Q3 24
27.1%
-16.1%
Q2 24
6.9%
-20.9%
Q1 24
32.7%
-28.0%
Net Margin
HNVR
HNVR
IRIX
IRIX
Q4 25
0.2%
Q3 25
19.4%
-12.6%
Q2 25
13.3%
-7.3%
Q1 25
8.3%
-14.2%
Q4 24
21.7%
-6.6%
Q3 24
20.7%
-16.7%
Q2 24
5.0%
-21.2%
Q1 24
24.6%
-29.5%
EPS (diluted)
HNVR
HNVR
IRIX
IRIX
Q4 25
$0.00
Q3 25
$0.47
$-0.09
Q2 25
$0.33
$-0.06
Q1 25
$0.20
$-0.10
Q4 24
$0.52
$-0.05
Q3 24
$0.48
$-0.12
Q2 24
$0.11
$-0.16
Q1 24
$0.55
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HNVR
HNVR
IRIX
IRIX
Cash + ST InvestmentsLiquidity on hand
$208.9M
$6.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$200.3M
Total Assets
$2.4B
$29.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HNVR
HNVR
IRIX
IRIX
Q4 25
$208.9M
$6.0M
Q3 25
$167.6M
$5.6M
Q2 25
$164.5M
$6.8M
Q1 25
$160.2M
$7.2M
Q4 24
$162.9M
$2.4M
Q3 24
$141.2M
$3.9M
Q2 24
$141.1M
$4.1M
Q1 24
$136.5M
$5.4M
Total Debt
HNVR
HNVR
IRIX
IRIX
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$1.0M
Q3 24
$1.4M
Q2 24
Q1 24
Stockholders' Equity
HNVR
HNVR
IRIX
IRIX
Q4 25
$200.3M
Q3 25
$201.8M
$4.7M
Q2 25
$198.9M
$6.1M
Q1 25
$196.6M
$852.0K
Q4 24
$196.6M
$2.1M
Q3 24
$192.3M
$2.6M
Q2 24
$190.1M
$4.2M
Q1 24
$189.5M
$6.5M
Total Assets
HNVR
HNVR
IRIX
IRIX
Q4 25
$2.4B
$29.2M
Q3 25
$2.3B
$28.4M
Q2 25
$2.3B
$31.6M
Q1 25
$2.3B
$34.2M
Q4 24
$2.3B
$29.1M
Q3 24
$2.3B
$30.2M
Q2 24
$2.3B
$31.2M
Q1 24
$2.3B
$34.1M
Debt / Equity
HNVR
HNVR
IRIX
IRIX
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.48×
Q3 24
0.53×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HNVR
HNVR
IRIX
IRIX
Operating Cash FlowLast quarter
$13.1M
Free Cash FlowOCF − Capex
$12.2M
FCF MarginFCF / Revenue
65.5%
Capex IntensityCapex / Revenue
4.7%
Cash ConversionOCF / Net Profit
395.48×
TTM Free Cash FlowTrailing 4 quarters
$16.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HNVR
HNVR
IRIX
IRIX
Q4 25
$13.1M
Q3 25
$2.7M
$-1.2M
Q2 25
$-2.1M
$-397.0K
Q1 25
$4.1M
$-1.1M
Q4 24
$5.4M
$-1.2M
Q3 24
$-547.0K
$-3.1M
Q2 24
$-3.1M
$-1.3M
Q1 24
$3.6M
$-1.6M
Free Cash Flow
HNVR
HNVR
IRIX
IRIX
Q4 25
$12.2M
Q3 25
$2.4M
$-1.2M
Q2 25
$-2.2M
$-410.0K
Q1 25
$3.9M
$-1.2M
Q4 24
$4.1M
$-1.2M
Q3 24
$-876.0K
$-3.1M
Q2 24
$-4.5M
Q1 24
$3.3M
$-1.7M
FCF Margin
HNVR
HNVR
IRIX
IRIX
Q4 25
65.5%
Q3 25
13.5%
-9.4%
Q2 25
-11.7%
-3.0%
Q1 25
21.2%
-9.8%
Q4 24
23.1%
-9.8%
Q3 24
-5.1%
-26.5%
Q2 24
-26.9%
Q1 24
19.9%
-14.0%
Capex Intensity
HNVR
HNVR
IRIX
IRIX
Q4 25
4.7%
Q3 25
1.8%
0.1%
Q2 25
0.5%
0.1%
Q1 25
1.2%
0.1%
Q4 24
7.2%
0.1%
Q3 24
1.9%
0.0%
Q2 24
8.6%
0.0%
Q1 24
1.9%
0.0%
Cash Conversion
HNVR
HNVR
IRIX
IRIX
Q4 25
395.48×
Q3 25
0.79×
Q2 25
-0.84×
Q1 25
2.70×
Q4 24
1.39×
Q3 24
-0.15×
Q2 24
-3.68×
Q1 24
0.89×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons